SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do I qualify for a cancer clinical trial?

2.

Short-course radiation matches standard therapy for endometrial cancer

3.

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

4.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

5.

Eight Doctors Killed in Brazil's Horrifying Plane Crash


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot